Recruiting Prurigo Nodularis Studies in Aventura
Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
This study is a Phase 3, randomized, modified double-blind study which aims to measure whether PCV21 vaccine (investigational pneumococcal conjugate vaccine) is safe and can help the body to develop g...
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis....
About Prurigo Nodularis Clinical Trials in Aventura
Prurigo nodularis is a chronic skin condition characterized by intensely itchy, hard lumps on the skin that develop from repeated scratching. It significantly impacts quality of life and sleep. Treatment includes topical therapies, phototherapy, and newer targeted biologics.
There are currently 2 prurigo nodularis clinical trials recruiting participants in Aventura, FL. These studies are seeking a combined 1,960 participants. Research is being sponsored by Sanofi Pasteur, a Sanofi Company, Incyte Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Prurigo Nodularis Clinical Trials in Aventura — FAQ
Are there prurigo nodularis clinical trials in Aventura?
Yes, there are 2 prurigo nodularis clinical trials currently recruiting in Aventura, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Aventura?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aventura research site will contact you about next steps.
Are clinical trials in Aventura free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aventura studies also compensate for your time and travel.
What prurigo nodularis treatments are being tested?
The 2 active trials in Aventura are testing new therapies including novel drugs, biologics, and treatment approaches for prurigo nodularis.
Data updated March 2, 2026 from ClinicalTrials.gov